It is more important than ever for Michigan to put ‘public pharma’ at the forefront of its public health policy. Placing the manufacturing, distribution, and pricing of prescription drugs like insulin into public, rather than corporate, hands offers a long-term solution to high-cost pharmaceuticals.
